As of 2025-05-16, the Relative Valuation of Amgen Inc (AMGN) is 146.11 USD. This relative valuation is based on P/E multiples. With the latest stock price at 271.69 USD, the upside of Amgen Inc based on Relative Valuation is -46.2%.
The range of the Relative Valuation is 132.55 - 161.11 USD.
| Range | Selected | |
| Trailing P/E multiples | 14.0x - 14.6x | 14.3x |
| Forward P/E multiples | 14.2x - 14.6x | 14.4x |
| Fair Price | 132.55 - 161.11 | 146.11 |
| Upside | -51.2% - -40.7% | -46.2% |
| Date | P/E |
| 2025-05-16 | 24.35 |
| 2025-05-15 | 24.62 |
| 2025-05-14 | 23.77 |
| 2025-05-13 | 24.51 |
| 2025-05-12 | 24.90 |
| 2025-05-09 | 24.09 |
| 2025-05-08 | 24.65 |
| 2025-05-07 | 25.00 |
| 2025-05-06 | 24.51 |
| 2025-05-05 | 25.38 |
| 2025-05-02 | 25.48 |
| 2025-05-01 | 25.72 |
| 2025-04-30 | 26.36 |
| 2025-04-29 | 26.15 |
| 2025-04-28 | 25.65 |
| 2025-04-25 | 25.45 |
| 2025-04-24 | 25.36 |
| 2025-04-23 | 25.18 |
| 2025-04-22 | 25.23 |
| 2025-04-21 | 24.80 |
| 2025-04-17 | 25.13 |
| 2025-04-16 | 25.61 |
| 2025-04-15 | 26.76 |
| 2025-04-14 | 26.64 |
| 2025-04-11 | 25.92 |
| 2025-04-10 | 25.50 |
| 2025-04-09 | 26.38 |
| 2025-04-08 | 25.40 |
| 2025-04-07 | 26.25 |
| 2025-04-04 | 26.68 |
| 2025-04-03 | 28.08 |
| 2025-04-02 | 27.70 |
| 2025-04-01 | 27.81 |
| 2025-03-31 | 28.23 |
| 2025-03-28 | 27.82 |
| 2025-03-27 | 27.71 |
| 2025-03-26 | 27.70 |
| 2025-03-25 | 27.81 |
| 2025-03-24 | 28.49 |
| 2025-03-21 | 28.64 |
| 2025-03-20 | 28.55 |
| 2025-03-19 | 28.61 |
| 2025-03-18 | 28.88 |
| 2025-03-17 | 28.74 |
| 2025-03-14 | 28.43 |
| 2025-03-13 | 28.33 |
| 2025-03-12 | 28.32 |
| 2025-03-11 | 28.90 |
| 2025-03-10 | 29.67 |
| 2025-03-07 | 29.44 |